Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways
Article in International Journal of Pharmaceutics X (December 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in International Journal of Pharmaceutics X (December 2024)
Article in European Urology Oncology (July 2024)
Article in Clinical Genitourinary Cancer (March 2024)